New Market - October 14, 2014
Probi to launch Probi Digestis in Brazil
Probi has signed a distribution agreement with Laboratório Daudt, the oldest Brazilian pharmaceutical company with market presence since 130 years. Following registration, Lab. Daudt plans to launch Probi Digestis during 2015. Probi AB and Lab. Daudt have agreed to launch the probiotic supplement – Probi Mage – on the Brazilian market. “Key to success in such a […]
New Market - September 26, 2014
Enzymatica gets first order for veterinary products
The company’s partner Adartis Animal Health has placed a first order for the veterinary products that Enzymatica launched in the United States and Canada in July 2014. The order includes Kalvatin products to a value of about SEK 3 million. According to Enzymatica the order is expected to cover market needs for the next six to […]
New Market - February 21, 2014
Novo Nordisk targets Mexico for anti-obesity drug
The Danish insulin maker plans to file for regulatory approval for the company’s new anti-obesity drug in Mexico, reports the Wall Street Journal. Novo Nordisk has reportedly targeted Mexico for an early launch of the treatment due to Mexico’s high percentage of overweight people, according to a statement from Mike Doustdar, senior vice president for international operations […]
New Market - January 31, 2014
Moberg Pharma gets approval in United Arab Emirates
The company’s partner Leosons International has received approval for Kerasal Nail in UAE. According to Moberg Pharma, launch preparations of the product will start immediately. In October 2013 a distribution agreement was signed sixteen markets in the MENA region (Middle East and North Africa). “We signed the distribution agreement with Leosons just three months ago. The rapid […]
New Market - January 20, 2014
Aerocrine signs UK & Irish partnership deal with Healthcare 21
Aerocrine has announces the signing of an exclusive agreement with UK & Irish medical device company Healthcare 21 for sales, marketing and distribution of Aerocrine’s new airway inflammation monitor and test kit – NIOX VERO – across the UK and Ireland. The agreement goes into effect on February 1, 2014 and gives Healthcare 21 exclusive […]
New Market - November 7, 2013
Enzymatica sets up a subsidiary in the USA
The biotech company, Enzymatica, is to offer a new product line, veterinary products, and is planning for sales in the North American market. The first products will be launched in mid-2014, and are expected to generate sales for Enzymatica during the second half of the year. Over the past few years, Enzymatica has devoted considerable […]
